Overview

Johannes Joseph "Jon" van Rood (7 April 1926 – 21 July 2017) was a Dutch immunologist best known for his work on human histocompatibility and for establishing an international organ allocation network. Born in Scheveningen, the Netherlands, he played a key role in the development of tissue-typing techniques that helped clinicians assess donor–recipient compatibility and reduce the risk of transplant rejection.

Scientific contributions

Van Rood's research contributed to the practical application of immunological principles in transplantation medicine. He helped refine methods for identifying human leukocyte antigens (HLA) and other markers relevant to compatibility between donors and recipients. These techniques became central to matching organs, bone marrow and other tissues, and they informed clinical protocols that improved graft survival and patient outcomes.

Founding of Eurotransplant

In 1967 van Rood founded Eurotransplant, a non-profit organization created to coordinate organ allocation and transplants across national borders. The organisation established procedures for registering donors and recipients, evaluating compatibility, and prioritizing cases according to medical urgency and compatibility criteria. Eurotransplant became a model for regional cooperation in organ sharing and helped increase the availability of suitable organs for transplant patients.

Awards, honours and positions

Van Rood received several major recognitions for his contributions to medicine and immunology. Notable honours include:

  • Robert Koch Prize (1977)
  • Wolf Prize in Medicine (1978), awarded jointly with George D. Snell and Jean Dausset — see award details
  • Membership of the Royal Netherlands Academy of Arts and Sciences (admitted 1978)

Later life and legacy

Van Rood remained a respected figure in transplant immunology throughout his life. His organizational work with Eurotransplant left a lasting institutional legacy: improved match-making between donors and recipients, broader sharing of scarce organs, and strengthened clinical cooperation across countries. He died on 21 July 2017 in Leeuwarden, the Netherlands; contemporary notices recorded his contributions and passing there.

Significance

While primarily trained and active as an immunologist, van Rood's enduring influence lies in translating laboratory knowledge into systems and practices that directly benefitted patients. The combination of technical advances in tissue typing with administrative innovation in organ exchange is widely regarded as a major factor in the modern era of transplantation medicine.